INS and type 2 diabetes mellitus: Early work has shown that people with type 2 diabetes who use CGM are younger, have higher HbA1c, are more likely to use insulin, and are more likely to receive endocrinology care than non-users.12 In type 1 diabetes, age ≥ 25 years,13 white race,14 higher socioeconomic status,14 and private health insurance14 are associated with CGM use, along with more diabetes self-care behaviors,14 less diabetes distress,15 and fewer depressive symptoms.14 However, studies assessing predictors measured before use, rather than correlates or outcomes measured alongside use, are limited.